Lv41
450 积分 2026-08-11 加入
Lebrikizumab in Atopic Dermatitis: Associations of Patient Characteristics and Treatment History with Clinical Outcomes
13天前
已完结
Long-term efficacy of lebrikizumab in treating head, neck and face involvement in patients with moderate-to-severe atopic dermatitis
13天前
已完结
Efficacy and safety of lebrikizumab in atopic dermatitis over 24 weeks: An analysis from the BIOREP registry
13天前
已完结
Real‐World Effectiveness of Lebrikizumab in Patients With Head–Neck Atopic Dermatitis: A Multicenter Study With Focus on Flare Occurrence
14天前
已完结
Lebrikizumab in Atopic Dermatitis: Associations of Patient Characteristics and Treatment History with Clinical Outcomes
14天前
已完结
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
19天前
已完结
70870 Predictors of Sustained Response After Dose Reduction in Moderate-to-Severe Atopic Dermatitis: A Systematic Review
21天前
已完结
Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry
21天前
已完结
Effectiveness and Safety of Omalizumab in the Adjuvant Treatment of Patients With Refractory Acute Urticaria: A Real‐World Case–Control Study
1个月前
已完结
[Expert consensus on the multidisciplinary integrated management of atopic dermatitis and its comorbidities(2026 edition)]
2个月前
已完结